Comparison of therapeutic effect on multi‐vessel coronary disease between minimally invasive coronary artery bypass grafting and coronary artery bypass grafting／
10.3969/j.issn.1008－0074.2019.04.14
- VernacularTitle:微创冠脉旁路移植术与冠脉旁路移植术治疗冠脉多支血管病变的疗效对比
- Author:
Zhao‐xia WANG
1
;
Ying‐min LU
;
Hong‐qiang LIU
;
Jin‐chun ZHANG
;
Da‐min HUANG
;
Xiao‐han LUO
;
Dong‐mei YUE
;
Jian JI
;
Lei SONG
;
Zhi‐hua LI
;
Wei‐ping XU
Author Information
1. 上海交通大学医学院附属新华医院崇明分院心内科
- Keywords:
Coronary artery disease;
Coronary artery bypass,off‐pump;
Treatment outcome
- From:
Chinese Journal of cardiovascular Rehabilitation Medicine
2019;28(4):446-450
- CountryChina
- Language:Chinese
-
Abstract:
To compare short‐and mid‐term therapeutic effect on aged patients with multi‐vessel coronary disease between minimally invasive coronary artery bypass grafting (MIDCAB) and coronary artery bypass grafting (CABG).Methods : A total of 72 patients with multi‐vessel disease , who were suitable for MIDCAB from 2016 to 2018 , were regarded as MIDCAB group .Another 96 patients with multi‐vessel disease , who were not suitable for MIDCAB , were enrolled as CABG group (received selective on‐pump CABG).Clinical data and incidence of major adverse cardio‐ and cerebrovascular events (MACCE ) within two‐year follow‐up were compared between two groups.Results : Men percentage of MIDCAB group was significantly higher than that of CABG group (83. 3% vs. 67. 7%, P＝0.022) ; compared with CABG group , there were significant reductions in percentages of left anterior descending proximal lesions (61.5% vs.34.7%) and chronic total occlusion disease (57.3% vs.34. 7%) in MID‐CAB group ( P＜0. 01 both) , there were no significant difference in other indexes between two groups , P＞ 0. 05 all.All subjects were followed up for two years , follow‐up rate was 90. 5% .There were no significant difference in incidence rates of all‐cause death and MACCE between two groups , P＞0.05 all.Conclusion : There is no signifi‐cant difference in incidence rate of short‐and mid‐term events between CABG and MIDCAB in patients with multi‐vessel coronary disease .MIDCAB is recommended for proper patients in clinic .
